FDA Inspection
Lilly del Caribe, Inc.Lilly del Caribe, Inc. – FDA Inspection, Apr 28, 2011
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc., with an inspection on April 28, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lilly del Caribe, Inc.
- Inspection Date
- April 28, 2011
- Product Type
- Drugs
View Company Profile
ID · 21f596f1-08d7-493f-aeaf-fe74e0c923c6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 721435
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 820.100(b)Documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lilly del Caribe, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2026 | Not classified | San Juan District Office | |
| February 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc.
- FDA Inspection 1321482 - 2026-05-12
- FDA Inspection 1198613 - 2023-02-17
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.